Fried Frank acted as counsel to Yellow Wood Partners in its US$585 million definitive agreement to buy the Dr. Scholl's business from Bayer. The transaction is expected to close in the fourth quarter of 2019. Yellow Wood Partners is a Boston-based private investment firm. Bayer is a multinational pharmaceutical and life sciences company. Dr. Scholl's is a footwear and orthopedic foot care brand.
The Fried Frank team was led by corporate partner Steven J. Steinman and included corporate partners Emil Buchman, Michael T. Gershberg, and David L. Shaw; executive compensation & ERISA partner Jeffrey Ross; intellectual property and technology partner Amir R. Ghavi; litigation partner Peter L. Simmons; tax partner Eli Weiss; corporate special counsel Michael Schneider; environmental special counsel Donna Mussio; intellectual property and technology special counsel Jason L. Greenberg; corporate associates Christopher S. Celentano, Moshe A. Cohen, Ryan P. Fitzpatrick, Kyle P. Langston, Roy Tannenbaum, and Asiya M. Ubaid; antitrust and competition associate John Todd Garcia Jr.; executive compensation & ERISA associate Adam P. Cohen; intellectual property and technology associates Kimberly L. Barr, Mina S. Reiman, and Daniel E. Stern; litigation associates Meghan McSkimming and Avani Uppalapati; and tax associate Tzvi Weisz.